171 related articles for article (PubMed ID: 7474132)
1. Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.
Duensing TD; Fang H; Dorward DW; Pincus SH
J Virol; 1995 Nov; 69(11):7122-31. PubMed ID: 7474132
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
Bour S; Boulerice F; Wainberg MA
J Virol; 1991 Dec; 65(12):6387-96. PubMed ID: 1942241
[TBL] [Abstract][Full Text] [Related]
3. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing.
Willey RL; Klimkait T; Frucht DM; Bonifacino JS; Martin MA
Virology; 1991 Sep; 184(1):319-29. PubMed ID: 1871974
[TBL] [Abstract][Full Text] [Related]
4. Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cells.
Zaides V; Yagello M; Veselovskaya T; Schmitt D; Rykova L; Fenouillet E; Gluckman JC
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2963-75. PubMed ID: 7964606
[TBL] [Abstract][Full Text] [Related]
5. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
[TBL] [Abstract][Full Text] [Related]
7. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
Fenouillet E; Jones IM
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
[TBL] [Abstract][Full Text] [Related]
8. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
Wells DE; Compans RW
Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957
[TBL] [Abstract][Full Text] [Related]
9. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
Willey RL; Maldarelli F; Martin MA; Strebel K
J Virol; 1992 Jan; 66(1):226-34. PubMed ID: 1727486
[TBL] [Abstract][Full Text] [Related]
11. Sequences in the rev-responsive element responsible for premature translational arrest in the human-immunodeficiency-virus-type-1 envelope.
Ellerbrok H; Serpente N; Pancino G; Vanhée C; D'Auriol L; Sitbon M; Vaquero C
Eur J Biochem; 1993 Sep; 216(2):459-67. PubMed ID: 8375384
[TBL] [Abstract][Full Text] [Related]
12. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors.
Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479
[TBL] [Abstract][Full Text] [Related]
13. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
Moulard M; Achstetter T; Kieny MP; Montagnier L; Bahraoui E
Eur J Biochem; 1994 Oct; 225(2):565-72. PubMed ID: 7957171
[TBL] [Abstract][Full Text] [Related]
14. Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells.
Fang H; Pincus SH
J Virol; 1995 Jan; 69(1):75-81. PubMed ID: 7983770
[TBL] [Abstract][Full Text] [Related]
15. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
[TBL] [Abstract][Full Text] [Related]
16. Processing and routage of HIV glycoproteins by furin to the cell surface.
Moulard M; Hallenberger S; Garten W; Klenk HD
Virus Res; 1999 Mar; 60(1):55-65. PubMed ID: 10225274
[TBL] [Abstract][Full Text] [Related]
17. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
Rodriguez D; Rodriguez JR; Esteban M
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1.
Lu YY; Koga Y; Tanaka K; Sasaki M; Kimura G; Nomoto K
J Virol; 1994 Jan; 68(1):390-9. PubMed ID: 7504739
[TBL] [Abstract][Full Text] [Related]
19. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
[TBL] [Abstract][Full Text] [Related]
20. Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
Pincus SH; Song K; Maresh GA; Hamer DH; Dimitrov DS; Chen W; Zhang MY; Ghetie VF; Chan-Hui PY; Robinson JE; Vitetta ES
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
